Generation Sequencing (NGS) market is set to surge from $14.79 billion in 2025 to $56.25 billion by 2033, with a robust CAGR of 18.17%. Key drivers include advancements in sequencing technologies, ...
Twice the output, half the runtime, and half the footprint of the UG 100® with greater flexibility and improved genomic ...
Element Biosciences AVITI24 5D Multiomic and AVITI next generation sequencing systems are designed to make high-performance genomics accessible to all. With its combination of accuracy, flexibility, ...
Reflecting on the strength of the community and engagement, Dr. Chaubey said, “Symposium 2026 is a living example of turning possibility into reality – a community united by the desire to be among the ...
Watchmaker Genomics, an innovator in high-performance solutions for next-generation sequencing (NGS), today announced a non-exclusive license with Caribou Biosciences, Inc., a leading clinical-stage ...
Southwest Florida companies Hertz, Herc, NeoGenomics, and Alico report Q4 and full-year 2025 earnings, showing mixed results.
Grail continues facing significant challenges as its stock plummeted over 45% after its landmark NHS-Galleri trial failed to meet its primary endpoint of reducing Stage III-IV cancer diagnoses despite ...
Cancer research continues to evolve as scientists strive to unravel the complexities of tumor biology, molecular signaling, and metabolic adaptations.
Scientists have developed an adaptable materials platform that can safely and efficiently deliver a wide range of genetic ...
Every year, millions of newborns undergo routine screening as a preventive strategy to detect inherited disorders before symptoms emerge. Newborn screening (NBS) programs have traditionally relied on ...
A review explores how next-generation sequencing may expand newborn screening and highlights key clinical and ethical challenges. Every year, millions of newborns undergo routine screening as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results